Answers are grounded in this paper and cite their sources.
Vaccination programmes increasingly face a paradox: expanding access does not necessarily translate into coverage at policy targets. Portugal provides an instructive example. The integration of community pharmacies into seasonal influenza and COVID-19 vaccination created more than 3,500 vaccination points and approximately 70% of influenza doses were administered in pharmacies in 2023–2024. The pharmacy share then fell to under 46% by 2025–2026, while total influenza doses remained broadly stable (2.41 to 2.56 million per season). This indicates a redistribution of doses across settings rather than a loss of vaccination activity; changes in age eligibility, high-dose vaccination for adults aged ≥85 years in SNS units, and invitation and recall activity may all have contributed. Influenza coverage among adults aged ≥65 years remained below the World Health Organization target of 75%, at 70.5% in 2024–2025 and 73.0% in 2025–2026. This suggests that, residual under-vaccination reflects barriers beyond physical access. The authors use “activation gap” descriptively for potentially addressable interruptions between eligibility and vaccination. Portugal already uses registry-based invitations and reminders, the open question is what a conversational layer, scripted or based on generative AI, could add. Evidence is relatively strong for reminders, growing for scripted conversational interventions and preliminary for generative AI. The authors therefore propose a registry-based randomised comparison of existing recall, existing recall plus a scripted conversational intervention, and existing recall plus a generative-AI conversational intervention, with incremental vaccination, safety, equity, trust and cost per additional vaccinated person as outcomes.
No takes yet. Share an insight, caveat, or question.
Goiana-da-Silva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: